LL37
$72.99
5mg
LL-37 is a 37–amino acid cationic peptide derived from the human cathelicidin precursor protein (hCAP18). It has been extensively studied in research settings for its role in innate immune signaling pathways, host–microbe interactions, and cellular processes related to epithelial repair and immune modulation.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
References
Venous Leg Ulcer Trial - Grönberg et al.
Wound Repair and Regeneration (2014)
68% ulcer area reduction demonstrated at optimal doses in chronic venous leg ulcers.
Melanoma Phase I Trial
(2015)
Intratumoral LL-37 in melanoma patients demonstrated safety and immune stimulation (NCT02225366).
MRSA Biofilm Study - Noore et al.
PLOS ONE (2019)
>4 log reduction in MRSA biofilms compared to conventional antibiotics.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
